Ayvens, a provider of sustainable mobility, delivered robust financial results for Q4 and full year 2024, marked by ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Q4 2024 Management View CEO Max Strandwitz highlighted 58% growth in net sales, with 52% organic growth for the quarter. Year-to-date organic growth reached 35%. He noted significant market share ...

Amazon’s Q4 2024 earnings call will take place today at 2 p.m. PT/5 p.m. ET. We’ll be streaming it on the Shacknews YouTube ...

Good morning and thank you all for joining us today for our Fourth Quarter 2024 Earnings Call. I'm joined by our CEO, Steve Hasker; and our CFO, Mike Eastwood, each of whom will discuss our results ...

Thank you for standing by, and welcome to the Honeywell fourth-quarter 2024 earnings conference call. [Operator instructions] ...

Colliers took in $1.5B in revenue in the fourth quarter, more than half of which came from recurring revenue, as sales and ...

Baron Growth Fund® (the Fund) gained 5.02% (Institutional Shares) for the year ended December 31, 2024. Read more here.

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Strategy (formerly MicroStrategy) reported a $1.016 billion Q4 2024 loss, largely due to Bitcoin impairment charges.

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Philip Morris International exceeded earnings expectations for Q4, propelled by its expanding smoke-free product lineup.